Tellgen Corp
Tellgen Corp provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical devices and related products.
Business. Tellgen Corp (300642.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Tellgen Corp (300642.SZ) is a healthcare services and equipment company operating within the medical equipment, supplies, and distribution industry. The firm is headquartered in China and is primarily listed on the Shenzhen Stock Exchange. Specific details regarding its operating segments and geographic revenue mix are not available.
Tellgen Corp maintains a capital structure with a debt-to-equity ratio of 0.31, indicating a relatively conservative leverage position compared to industry norms. The company's liquidity is assessed as medium, with a current ratio of 4.91, suggesting strong short-term liquidity. However, the company's free cash flow is negative at -36,003,150 CNY, and capital expenditures are significant at -67,337,580 CNY, indicating ongoing investment in operations.
Profitability metrics for Tellgen Corp show a return on equity (ROE) of 0.0025 and a return on assets (ROA) of 0.0017, both of which are below the industry median for medical equipment and supplies firms. The company's operating income is negative at -2,789,980 CNY, while net income is positive at 3,587,910 CNY, suggesting that non-operating income or gains are offsetting operational losses.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification increases exposure to regional economic or regulatory shifts. Tellgen Corp's revenue concentration in a single segment and geographic area is a notable risk factor.
Tellgen Corp's growth trajectory is mixed. While the company's revenue for the latest period is 363,829,000 CNY, the operating cash flow is positive at 143,232,890 CNY, indicating some operational strength. However, the negative free cash flow and high capital expenditures suggest that the company is reinvesting heavily in its operations, which may limit near-term growth in earnings.
The company's risk profile includes a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt highlights potential liquidity constraints. The dilution risk is low, with no significant dilution sources identified in the latest filings.
Recent events and filings for Tellgen Corp do not indicate any material changes in the company's operations or financial position. The company's latest financial statements show a continuation of its current operational and financial trends, with no significant new developments reported in the latest disclosures.
- Tellgen Corp has a conservative debt-to-equity ratio of 0.31, indicating a relatively low leverage position.
- The company's ROE and ROA are below industry medians, suggesting subpar profitability.
- Tellgen Corp's revenue is concentrated in a single business segment, increasing exposure to regional and sector-specific risks.
- The company's free cash flow is negative, and capital expenditures are high, indicating ongoing investment in operations.
- Tellgen Corp's liquidity is assessed as medium, with a current ratio of 4.91, but the company has negative net cash after subtracting total debt.
- The company's dilution risk is low, with no significant dilution sources identified in the latest filings.
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Ev To Operating Cash Flowenterprise_value / operating_cash_flow
- Return On Equitynet_income / total_equity
- Price To Earningsmarket_price / (net_income / shares_outstanding_diluted)
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Tellgen Corp Market data — financials · 2026-05-26